▲ +3.16% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for 1Life Healthcare in the last 3 months. The average price target is $37.08, with a high forecast of $44.00 and a low forecast of $24.00. The average price target represents a 3.16% upside from the last price of $35.94.
The current consensus among 12 polled investment analysts is to buy stock in 1Life Healthcare.
1Life Healthcare, Inc. operates a membership-based primary care platform. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2019, it had approximately 422,000 members in nine markets in the United States; and 7,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.